Cerenovus announces clinical data and product showcases ahead of SNIS 2022

3047

cerenovus snis 2022Cerenovus, part of Johnson & Johnson MedTech, will showcase its latest innovations in stroke care at the 2022 Society of NeuroInterventional Surgery (SNIS) annual meeting (25–29 July, Toronto, Canada). The company is set to announce new clinical data during poster sessions and feature product innovations across its ischaemic and haemorrhagic portfolios that “reflect the company’s continued commitment to changing the trajectory of stroke”, as per a press release.

“When it comes to stroke, we recognise the continuing opportunity to address unmet clinical needs, which ultimately can provide better outcomes for both patients and physicians,” said Mark Dickinson, worldwide president, Cerenovus. “We are looking forward to sharing our latest research and newest additions to our ischaemic and haemorrhagic portfolios that build on our commitment to changing the trajectory of stroke.”

Cerenovus is supporting two scientific poster sessions at SNIS 2022, including one oral presentation on Monday 25 July, entitled “Interim safety and occlusion outcomes of endovascular treatment of ‘very small intracranial aneurysms’ in the STERLING registry”, and one e-poster, entitled “PulseRider-assisted treatment of intracranial aneurysms in the STERLING registry”.

The company will also host a variety of interactive experiences at Booth 201, including hands-on demonstrations featuring technologies from its ischaemic and haemorrhagic portfolios.

In addition, Cerenovus will debut an institution-oriented racial disparity in stroke care (RDiSC) metric picklist tool at the booth. According to the release, the RDiSC tool can be used to assess and benchmark a hospital’s stroke outcomes across their patient population by race. The insight derived may be used to uncover focus areas of improvement in closing the racial disparity gap that exist along the stroke care pathway.

Cerenovus will also sponsor multiple programmes and receptions at SNIS 2022, including the Women in Neurointervention Leadership Program; Diversity, Equity and Inclusion Reception; Annual Women in NeuroIntervention Dinner; and Fellows Course Hands-On Lab and Reception.


LEAVE A REPLY

Please enter your comment!
Please enter your name here